Imunon (IMNN) CFO Joshua Blacher files initial insider Form 3 ownership report
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Imunon, Inc. CFO Joshua Blacher files an initial ownership report on Form 3. This filing identifies Blacher as an officer of the company with the title of Chief Financial Officer. The data provided does not list any specific transactions or derivative positions, indicating this is a baseline disclosure of his status as a reporting person under SEC rules.
Positive
- None.
Negative
- None.
Key Terms
Form 3, reporting person, beneficial ownership
3 terms
Form 3 regulatory
"files an initial ownership report on Form 3"
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
reporting person regulatory
"identifies Joshua Blacher as a reporting person and its Chief Financial Officer"
beneficial ownership financial
"initial statement of beneficial ownership, bringing him under ongoing SEC insider reporting requirements"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
FAQ
What does Imunon (IMNN) disclose about Joshua Blacher in this Form 3?
Imunon identifies Joshua Blacher as a reporting person and its Chief Financial Officer in this Form 3. The filing serves as an initial statement of beneficial ownership, bringing him under ongoing SEC insider reporting requirements as an officer.
Are any derivative securities reported for Imunon (IMNN) CFO Joshua Blacher?
The Form 3 data for Imunon CFO Joshua Blacher shows no derivative securities. The derivative section is empty and the derivative transaction count is zero, indicating no options, warrants, or similar instruments are listed in this initial ownership statement.
Why is Joshua Blacher required to file a Form 3 for Imunon (IMNN)?
As Imunon’s Chief Financial Officer, Joshua Blacher is considered an officer and therefore an insider under SEC rules. Insiders must file Form 3 to provide an initial statement of beneficial ownership when they become subject to Section 16 reporting obligations.
Does this Imunon (IMNN) Form 3 indicate buying or selling by the CFO?
The Form 3 for Imunon CFO Joshua Blacher shows no buying or selling activity. All transaction counts and share totals for purchases, sales, exercises, gifts, and tax withholdings are zero, so it does not reflect any trading decisions by the officer.